Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association

Steven E. Lipshultz, Yuk M. Law, Alfred Asante-Korang, Eric D. Austin, Anne I. Dipchand, Melanie D. Everitt, Daphne T. Hsu, Kimberly Y. Lin, Jack F. Price, James D. Wilkinson, Steven D. Colan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In this scientific statement from the American Heart Association, experts in the field of cardiomyopathy (heart muscle disease) in children address 2 issues: the most current understanding of the causes of cardiomyopathy in children and the optimal approaches to diagnosis cardiomyopathy in children. Cardiomyopathies result in some of the worst pediatric cardiology outcomes; nearly 40% of children who present with symptomatic cardiomyopathy undergo a heart transplantation or die within the first 2 years after diagnosis. The percentage of children with cardiomyopathy who underwent a heart transplantation has not declined over the past 10 years, and cardiomyopathy remains the leading cause of transplantation for children >1 year of age. Studies from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry have shown that causes are established in very few children with cardiomyopathy, yet genetic causes are likely to be present in most. The incidence of pediatric cardiomyopathy is ≈1 per 100 000 children. This is comparable to the incidence of such childhood cancers as lymphoma, Wilms tumor, and neuroblastoma. However, the published research and scientific conferences focused on pediatric cardiomyopathy are sparcer than for those cancers. The aim of the statement is to focus on the diagnosis and classification of cardiomyopathy. We anticipate that this report will help shape the future research priorities in this set of diseases to achieve earlier diagnosis, improved clinical outcomes, and better quality of life for these children and their families.

Original languageEnglish (US)
Pages (from-to)E9-E68
JournalCirculation
Volume140
Issue number1
DOIs
StatePublished - Jul 2 2019

Fingerprint

Cardiomyopathies
Pediatrics
Heart Transplantation
National Heart, Lung, and Blood Institute (U.S.)
Wilms Tumor
Incidence
Cardiology
Neuroblastoma
Research
Registries
Early Diagnosis
Heart Diseases
Lymphoma
Neoplasms
Myocardium
Transplantation
Quality of Life

Keywords

  • AHA Scientific Statements
  • cardiomyopathies
  • child
  • genetics
  • heart failure
  • heart transplantation
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Lipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., ... Colan, S. D. (2019). Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation, 140(1), E9-E68. https://doi.org/10.1161/CIR.0000000000000682

Cardiomyopathy in Children : Classification and Diagnosis: A Scientific Statement From the American Heart Association. / Lipshultz, Steven E.; Law, Yuk M.; Asante-Korang, Alfred; Austin, Eric D.; Dipchand, Anne I.; Everitt, Melanie D.; Hsu, Daphne T.; Lin, Kimberly Y.; Price, Jack F.; Wilkinson, James D.; Colan, Steven D.

In: Circulation, Vol. 140, No. 1, 02.07.2019, p. E9-E68.

Research output: Contribution to journalArticle

Lipshultz, SE, Law, YM, Asante-Korang, A, Austin, ED, Dipchand, AI, Everitt, MD, Hsu, DT, Lin, KY, Price, JF, Wilkinson, JD & Colan, SD 2019, 'Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association', Circulation, vol. 140, no. 1, pp. E9-E68. https://doi.org/10.1161/CIR.0000000000000682
Lipshultz, Steven E. ; Law, Yuk M. ; Asante-Korang, Alfred ; Austin, Eric D. ; Dipchand, Anne I. ; Everitt, Melanie D. ; Hsu, Daphne T. ; Lin, Kimberly Y. ; Price, Jack F. ; Wilkinson, James D. ; Colan, Steven D. / Cardiomyopathy in Children : Classification and Diagnosis: A Scientific Statement From the American Heart Association. In: Circulation. 2019 ; Vol. 140, No. 1. pp. E9-E68.
@article{117d52ccaf80416294ffc502a5d9ab47,
title = "Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association",
abstract = "In this scientific statement from the American Heart Association, experts in the field of cardiomyopathy (heart muscle disease) in children address 2 issues: the most current understanding of the causes of cardiomyopathy in children and the optimal approaches to diagnosis cardiomyopathy in children. Cardiomyopathies result in some of the worst pediatric cardiology outcomes; nearly 40{\%} of children who present with symptomatic cardiomyopathy undergo a heart transplantation or die within the first 2 years after diagnosis. The percentage of children with cardiomyopathy who underwent a heart transplantation has not declined over the past 10 years, and cardiomyopathy remains the leading cause of transplantation for children >1 year of age. Studies from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry have shown that causes are established in very few children with cardiomyopathy, yet genetic causes are likely to be present in most. The incidence of pediatric cardiomyopathy is ≈1 per 100 000 children. This is comparable to the incidence of such childhood cancers as lymphoma, Wilms tumor, and neuroblastoma. However, the published research and scientific conferences focused on pediatric cardiomyopathy are sparcer than for those cancers. The aim of the statement is to focus on the diagnosis and classification of cardiomyopathy. We anticipate that this report will help shape the future research priorities in this set of diseases to achieve earlier diagnosis, improved clinical outcomes, and better quality of life for these children and their families.",
keywords = "AHA Scientific Statements, cardiomyopathies, child, genetics, heart failure, heart transplantation, sudden death",
author = "Lipshultz, {Steven E.} and Law, {Yuk M.} and Alfred Asante-Korang and Austin, {Eric D.} and Dipchand, {Anne I.} and Everitt, {Melanie D.} and Hsu, {Daphne T.} and Lin, {Kimberly Y.} and Price, {Jack F.} and Wilkinson, {James D.} and Colan, {Steven D.}",
year = "2019",
month = "7",
day = "2",
doi = "10.1161/CIR.0000000000000682",
language = "English (US)",
volume = "140",
pages = "E9--E68",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cardiomyopathy in Children

T2 - Classification and Diagnosis: A Scientific Statement From the American Heart Association

AU - Lipshultz, Steven E.

AU - Law, Yuk M.

AU - Asante-Korang, Alfred

AU - Austin, Eric D.

AU - Dipchand, Anne I.

AU - Everitt, Melanie D.

AU - Hsu, Daphne T.

AU - Lin, Kimberly Y.

AU - Price, Jack F.

AU - Wilkinson, James D.

AU - Colan, Steven D.

PY - 2019/7/2

Y1 - 2019/7/2

N2 - In this scientific statement from the American Heart Association, experts in the field of cardiomyopathy (heart muscle disease) in children address 2 issues: the most current understanding of the causes of cardiomyopathy in children and the optimal approaches to diagnosis cardiomyopathy in children. Cardiomyopathies result in some of the worst pediatric cardiology outcomes; nearly 40% of children who present with symptomatic cardiomyopathy undergo a heart transplantation or die within the first 2 years after diagnosis. The percentage of children with cardiomyopathy who underwent a heart transplantation has not declined over the past 10 years, and cardiomyopathy remains the leading cause of transplantation for children >1 year of age. Studies from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry have shown that causes are established in very few children with cardiomyopathy, yet genetic causes are likely to be present in most. The incidence of pediatric cardiomyopathy is ≈1 per 100 000 children. This is comparable to the incidence of such childhood cancers as lymphoma, Wilms tumor, and neuroblastoma. However, the published research and scientific conferences focused on pediatric cardiomyopathy are sparcer than for those cancers. The aim of the statement is to focus on the diagnosis and classification of cardiomyopathy. We anticipate that this report will help shape the future research priorities in this set of diseases to achieve earlier diagnosis, improved clinical outcomes, and better quality of life for these children and their families.

AB - In this scientific statement from the American Heart Association, experts in the field of cardiomyopathy (heart muscle disease) in children address 2 issues: the most current understanding of the causes of cardiomyopathy in children and the optimal approaches to diagnosis cardiomyopathy in children. Cardiomyopathies result in some of the worst pediatric cardiology outcomes; nearly 40% of children who present with symptomatic cardiomyopathy undergo a heart transplantation or die within the first 2 years after diagnosis. The percentage of children with cardiomyopathy who underwent a heart transplantation has not declined over the past 10 years, and cardiomyopathy remains the leading cause of transplantation for children >1 year of age. Studies from the National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry have shown that causes are established in very few children with cardiomyopathy, yet genetic causes are likely to be present in most. The incidence of pediatric cardiomyopathy is ≈1 per 100 000 children. This is comparable to the incidence of such childhood cancers as lymphoma, Wilms tumor, and neuroblastoma. However, the published research and scientific conferences focused on pediatric cardiomyopathy are sparcer than for those cancers. The aim of the statement is to focus on the diagnosis and classification of cardiomyopathy. We anticipate that this report will help shape the future research priorities in this set of diseases to achieve earlier diagnosis, improved clinical outcomes, and better quality of life for these children and their families.

KW - AHA Scientific Statements

KW - cardiomyopathies

KW - child

KW - genetics

KW - heart failure

KW - heart transplantation

KW - sudden death

UR - http://www.scopus.com/inward/record.url?scp=85069267107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069267107&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000682

DO - 10.1161/CIR.0000000000000682

M3 - Article

C2 - 31132865

AN - SCOPUS:85069267107

VL - 140

SP - E9-E68

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1

ER -